Moritz SchmidtLabhead Molecular Biology at Boehringer Ingelheim
Profile
Dr. Moritz Schmidt received his PhD at the department of chemistry in Konstanz, Germany, for his contributions to the field of genetic code expansion using non-canonical amino acids. Dr. Schmidt joined the biologics research department at Bayer 2016 to drive explorative projects in the field of gene therapy and genome editing. In 2019 Dr. Schmidt joined Boehringer Ingelheim as a head of laboratory within the cell line development department, where his work is focused on advancing current cell line development technologies.
Agenda Sessions
From Transfection to FIH in 6 Months: How Advances in Cell Line Development Enabled Manufacturing of Monoclonal Antibodies at Unprecedented Pace
, 10:45View Session